Peptides for treatment of inflammation and shock

Details Peptides for treatment of inflammation and shock Peptides for treatment of inflammation and shock

2005-02-08

2005-02-08

Campell, Bruce R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S017400, C514S018700, C530S328000, C530S329000, C530S330000, C530S331000

Reexamination Certificate

active

06852697

ABSTRACT:
Submandibular peptides have been isolated and characterized and provide pharmaceutical compositions for the treatment or prevention of anaphylactic reactions, endotoxic reactions and SIRS-induced shock.

REFERENCES:
patent: 4880779 (1989-11-01), Gallaher
patent: 9211858 (1992-07-01), None
Slootstra, et al., “Structural Aspects of Antibody-Antigen Interaction Revealed Through Small Random Peptide Libaries” Molecular Diversity 1996, 1, 87-96.*
Grant, G.A., Synthetic Peptides: A User's Guide W.H. Freeman & Company: 1992, p. 53.*
Wilkes, et al., “Critical Ionizing Groups in Aeromonas Neutral Protease”, J. Biol. Chem. 1988, 263, (4), 1821-1825.*
Ngo et al., ‘Computational Complexity, Potein Structure Prediction, and the Levinthal Paradox,’ The Protein Folding Problem and Tertiary Structuer Prediction. Ed. K. Merz and L. Le Grand. BirkHauser, Boston MA. pp. 491-495. 1994.*
Rudinger, J. (1976). Peptide Hormones (ed. J.A. Parsons). University Park Press. Baltimore. pp 1-7. 1976.*
Slootstra et al. J.W.: ‘Structural Aspects of Antibody-Antigen Interaction . . . ’ Molecular Diversity, vol. 1, 1996, p. 87-96.*
Fiie caplus on STN. No. 82:151333. Abramowitz-Kurn et al. ‘Mapping the Active Site of Carboxypetidase A. Proposed Scheme for Substrate Binding at the Active Site’, Isr. J. Chem. vol. 12 (1-2), pp. 543-555. 1974 (abstract only).*
Barka, T. J Histochem Cytochem 1980; 28: 836-859.
Boyer, R. et al, Ann Endocrinologie (Paris) 1991; 52: 307-322.
Mathison, R. et al, Immunology Today 1994; 15: 527-532.
Epstein, J.B. et al, J Canadian Dent Ass 1992; 58: 217-221.
Kingsnorth, A.N. et al, Br. J. Surg. 1990; 77: 409-412.
Skinner, K. et al, Gastroenterology 1981; 81: 335-339.
Gray, M.R. et al, Br. J. Surg. 1991; 78: 1461-1466.
Kurachi, H. et al, Proc. Natl. Acad. Sci. 1985; 82: 5940-5943.
Jones, Jr. D.E. et al, Am. J. Physiol. 1995: 268: G872-G878.
Amano, O. et al, Growth Factors 1994; 10: 145-151.
Tsutsumi, O. et al; Science 1986; 233: 975-977.
Tsutsumi, O. et al, J. Endocrinol 1993; 138: 437-443.
Rosinski-Chupin et al, (1990) DNA Cell Biol., v. 9, pp. 553-559.
Rosinski-Chupin et al, (1988), P.N.A.S. USA, v. 85, pp. 8553-8557.
Kemp, A. et al, Suppression and enhancement of in vitro lymphocyte reactivity by factors in rat submandbular gland extracts. Immunology 1985; 56: 261-267.
Abdelhaleem M. et al, Identification of immunosuppressive fractions from the rat submandibular salivary gland. Immunology 1992; 76: 331-337.
Bissonnette, E. et al, Decentralization of the superior cervical ganglia inhibits mast cell mediated TNFα cytotoxicity 1 Potential role of salivary glands Brain, Behavior & Immunity 1993; 7: 293-300.
Carter, L. et al, Inhibition of neutrophil chemotaxis and activation following decentralization of the superior cervical ganglia. J. Leukocyte Biol. 1992; 51: 597-602.
Saito, K. et al, Saliva inhibits chemiluminescence response, phagocytosis and killing of Staphylococcus epidermidis by polymorphonuclear leukocytes, Infect. Immun. 1988; 56: 2125-2132.
Ramaswamy K. et al, Regulation of inflammatory cell function by bilateral decentralization of the superior cervical ganglion, J. Exp. Med. 1990; 172: 1819-1830.
Mathison, R. et al, Role for the submandibular gland in modulating pulmonary inflammation following induction of systemic anaphylaxis. Brain, Behavior and Immunity 1992; 6: 117-129.
Mathison, R. et al, Temporal analysis of the anti-inflammatory effects of decentralization of the superior cervical ganglia, Am. J. Physiol. 1994; 266: R1537-R1543.
Mathison, R. et al, Removal of the submandibular glands increases the acute hypotensive response to endotoxin, Circ. Shock 1993: 39: 52-58.
Bachem AG Catalog. F13-1993, pp. 203 and 533.
Abderhalden et al, (1942), FERMENTFORSCHUNG, v. 16, pp. 98-114.
Slootstra et al., (1996), Molecular Diversity, v. 1, pp. 87-96.

Affiliated with

Also associated with

Rating

Peptides for treatment of inflammation and shock does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides for treatment of inflammation and shock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for treatment of inflammation and shock will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3512273